The Treatment of Narcolepsy With Amphetamine-Based Stimulant Medications: A Call for Better Understanding

Overview

Journal J Clin Sleep Med

Specialties Neurology
Psychiatry

Date 2019 May 5

PMID 31053220

Citations 3

Authors

Moshe Turner

Affiliations

Soon will be listed here.

Citing Articles

Sleep Loss and Substance Use Disorders: An Issue from Adolescents to Adults.

Equihua-Benitez A, Espinoza-Abad R, Garcia-Garcia F Behav Sci (Basel). 2025; 15(2).

PMID: 40001851 PMC: 11852296. DOI: 10.3390/bs15020220.

Restoration of norepinephrine release, cognitive performance, and dendritic spines by amphetamine in aged rat brain.

Scognamiglio S, Aljohani Y, Olson T, Forcelli P, Dezfuli G, Kellar K Aging Cell. 2024; 23(4):e14087.

PMID: 38332648 PMC: 11019150. DOI: 10.1111/acel.14087.

Amphetamines in child medicine: a review of ClinicalTrials.gov.

Alalalmeh S, Hegazi O, Shahwan M, Alshehri F, Ashour A, Algarni A Front Pharmacol. 2023; 14:1280562.

PMID: 37854716 PMC: 10579567. DOI: 10.3389/fphar.2023.1280562.

Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits.

Kassim F Hum Psychopharmacol. 2022; 38(1):e2856.

PMID: 36251504 PMC: 10078276. DOI: 10.1002/hup.2856.

References

Nishino S, Ripley B, Overeem S, Lammers G, Mignot E . Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000; 355(9197):39-40. DOI: 10.1016/S0140-6736(99)05582-8. View

Burlet S, Tyler C, Leonard C . Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci. 2002; 22(7):2862-72. PMC: 6758338. DOI: 20026234. View

Kukkonen J, Holmqvist T, Ammoun S, Akerman K . Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol. 2002; 283(6):C1567-91. DOI: 10.1152/ajpcell.00055.2002. View

Ebrahim I, Sharief M, De Lacy S, Semra Y, Howard R, Kopelman M . Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. J Neurol Neurosurg Psychiatry. 2002; 74(1):127-30. PMC: 1738182. DOI: 10.1136/jnnp.74.1.127. View

Longstreth Jr W, Koepsell T, Ton T, Hendrickson A, van Belle G . The epidemiology of narcolepsy. Sleep. 2007; 30(1):13-26. DOI: 10.1093/sleep/30.1.13. View

Morgenthaler T, Kapur V, Brown T, Swick T, Alessi C, Aurora R . Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep. 2008; 30(12):1705-11. PMC: 2276123. DOI: 10.1093/sleep/30.12.1705. View

Aston-Jones G, Smith R, Moorman D, Richardson K . Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology. 2008; 56 Suppl 1:112-21. PMC: 2635332. DOI: 10.1016/j.neuropharm.2008.06.060. View

Nunez A, Rodrigo-Angulo M, Andres I, Garzon M . Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis. Curr Neuropharmacol. 2009; 7(1):50-9. PMC: 2724663. DOI: 10.2174/157015909787602797. View

Borgland S, Chang S, Bowers M, Thompson J, Vittoz N, Floresco S . Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci. 2009; 29(36):11215-25. PMC: 2771749. DOI: 10.1523/JNEUROSCI.6096-08.2009. View

10.

Espana R, Oleson E, Locke J, Brookshire B, Roberts D, Jones S . The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci. 2009; 31(2):336-48. PMC: 2881680. DOI: 10.1111/j.1460-9568.2009.07065.x. View

11.

Blouin A, Fried I, Wilson C, Staba R, Behnke E, Lam H . Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction. Nat Commun. 2013; 4:1547. PMC: 3595130. DOI: 10.1038/ncomms2461. View

12.

Inutsuka A, Yamanaka A . The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions. Front Endocrinol (Lausanne). 2013; 4:18. PMC: 3589707. DOI: 10.3389/fendo.2013.00018. View

13.

Brown R, Lawrence A . Ascending orexinergic pathways and alcohol-seeking. Curr Opin Neurobiol. 2013; 23(4):467-72. DOI: 10.1016/j.conb.2013.02.014. View

14.

Bayard S, Dauvilliers Y . Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy. Front Behav Neurosci. 2013; 7:50. PMC: 3661950. DOI: 10.3389/fnbeh.2013.00050. View

15.

Frauscher B, Ehrmann L, Mitterling T, Gabelia D, Gschliesser V, Brandauer E . Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the innsbruck narcolepsy cohort. J Clin Sleep Med. 2013; 9(8):805-12. PMC: 3716672. DOI: 10.5664/jcsm.2926. View

16.

Rosenberg R, Kim A . The AWAKEN survey: knowledge of narcolepsy among physicians and the general population. Postgrad Med. 2014; 126(1):78-86. DOI: 10.3810/pgm.2014.01.2727. View

17.

Baimel C, Bartlett S, Chiou L, Lawrence A, Muschamp J, Patkar O . Orexin/hypocretin role in reward: implications for opioid and other addictions. Br J Pharmacol. 2014; 172(2):334-48. PMC: 4292951. DOI: 10.1111/bph.12639. View

18.

Muschamp J, Hollander J, Thompson J, Voren G, Hassinger L, Onvani S . Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. Proc Natl Acad Sci U S A. 2014; 111(16):E1648-55. PMC: 4000785. DOI: 10.1073/pnas.1315542111. View

19.

Klein G, Burghaus L, Vaillant M, Pieri V, Fink G, Diederich N . Dysautonomia in narcolepsy: evidence by questionnaire assessment. J Clin Neurol. 2014; 10(4):314-9. PMC: 4198712. DOI: 10.3988/jcn.2014.10.4.314. View

20.

de Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P . The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998; 95(1):322-7. PMC: 18213. DOI: 10.1073/pnas.95.1.322. View